100% of moneycontrol users recommend buying Surya Pharma.
What's your call on Surya Pharma today?
Read 3 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2923.15||1.13||2941.10||2198.35||49,791.49|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
RS Software (India) Recommended on Aug 12th 2014
Recommended price 430.00 | Peak from reco 585.50 36.16%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Surya Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 31.02 crore.The company has reported a standalone sales of Rs 0.57 crore and a Net Loss of Rs -867.83 crore for the quarter ended Dec 2013.
The company management includes Rajiv Goyal - Chairman & Managing Director, Alka Goyal - Executive Director, Subhash Chander Marwaha - Nominee Director, Jasvinder Singh - Addnl. & Ind.Director.
It is listed on the BSE with a BSE Code of 532516 and the NSE with an NSE Code of SURYAPHARM.
Its Registered office is at 1956, 1st Floor, Bhagirath Place,,Chandni Chowk New Delhi,Delhi - 110006.
Their Registrars are Bigshare Services Pvt. Ltd.